Andrew Quon
Overview
Explore the profile of Andrew Quon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kong F, Hu C, Pryma D, Duan F, Matuszak M, Xiao Y, et al.
J Clin Oncol
. 2024 Oct;
42(33):3935-3946.
PMID: 39365957
Purpose: NRG-RTOG0617 demonstrated a detrimental effect of uniform high-dose radiation in stage III non-small cell lung cancer. NRG-RTOG1106/ECOG-ACRIN6697 (ClinicalTrials.gov identifier: NCT01507428), a randomized phase II trial, studied whether midtreatment F-fluorodeoxyglucose...
2.
Maliha P, Hotta M, Farolfi A, Grogan T, Alano R, Limon A, et al.
Eur J Nucl Med Mol Imaging
. 2024 May;
51(11):3373-3385.
PMID: 38750372
Purpose: Fibroblast activation protein (FAP)-inhibitor (FAPI)-PET tracers allow imaging of the FAP-expressing cancer associated fibroblasts (CAF) and also the normal activated fibroblasts (NAF) involved in inflammation/fibrosis that may be present...
3.
Jun M, Pinto H, Le Q, Quon A, Hara W, Coty J, et al.
PLoS One
. 2023 Feb;
18(2):e0276651.
PMID: 36730145
Objectives: A phase II = design is used to evaluate the efficacy and feasibility of full dose docetaxel, platinum, and 5-fluorouracil (TPF) in a sequential chemoradiation treatment locally advanced (LA)...
4.
Sodji Q, Harris J, Quon A, Modlin L, Lau B, Jiang A, et al.
Clin Lung Cancer
. 2022 Mar;
23(3):282-289.
PMID: 35246393
Introduction/background: Differentiating local recurrence (LR) from post-treatment changes following stereotactic ablative radiotherapy (SABR) for thoracic tumors is challenging. We sought to evaluate the performance of FDG-PET-CT in distinguishing recurrence from...
5.
Calais J, Czernin J, Thin P, Gartmann J, Nguyen K, Armstrong W, et al.
J Nucl Med
. 2021 Jul;
62(10):1447-1456.
PMID: 34272322
The purpose of this analysis was to report the safety evaluation of Lu-PSMA-617 derived from the cohort of 64 patients exposed to Lu-PSMA-617 in the RESIST-PC trial NCT03042312 RESIST-PC was...
6.
Benz M, Armstrong W, Ceci F, Polverari G, Donahue T, Wainberg Z, et al.
J Nucl Med
. 2021 Jul;
63(2):199-204.
PMID: 34272317
The purpose of this study was to evaluate F-FDG PET/CT as an early and late interim imaging biomarker in patients with pancreatic ductal adenocarcinoma who undergo first-line systemic therapy. This...
7.
Calais J, Gafita A, Eiber M, Armstrong W, Gartmann J, Thin P, et al.
J Nucl Med
. 2021 May;
62(10):1440-1446.
PMID: 34016732
The objective of this study was to determine prospectively the efficacy profile of 2 activity regimens of Lu-PSMA therapy in patients with progressive metastatic castrate-resistant prostate cancer (mCRPC): 6.0 vs....
8.
Minamimoto R, Fayad L, Vose J, Meza J, Advani R, Hankins J, et al.
Eur J Nucl Med Mol Imaging
. 2021 Apr;
48(9):2883-2893.
PMID: 33909086
Purpose: To determine whether interim 3'-deoxy-3'-[F]fluorothymidine (iFLT) PET/CT is a superior predictor of progression-free survival (PFS) compared with interim F-fluorodeoxyglucose (iFDG) PET/CT in patients with diffuse large B cell lymphoma...
9.
Evens A, Hong F, Habermann T, Advani R, Gascoyne R, Witzig T, et al.
Clin Cancer Res
. 2020 Jun;
26(17):4468-4477.
PMID: 32532790
Purpose: We sought to improve upon frontline bendamustine/rituximab (BR) induction therapy followed by rituximab maintenance in untreated high-risk follicular lymphoma (FL). Patients And Methods: Patients were randomized to BR induction...
10.
Chen B, Ghezzi C, Villegas B, Quon A, Radu C, Witte O, et al.
J Nucl Med
. 2019 Oct;
61(5):757-763.
PMID: 31653711
Brain-infiltrating leukocytes contribute to multiple sclerosis (MS) and autoimmune encephalomyelitis and likely play a role in traumatic brain injury, seizure, and stroke. Brain-infiltrating leukocytes are also primary targets for MS...